Childhood hypo-adiponectinaemia but not hyper-leptinaemia is associated with insulin insensitivity 6 years later

Iben Kynde1, Berit Lilienthal Heitmann, Ib Christian Bygbjerg

  • 1Department of Biomedical Sciences, Centre for Healthy Ageing, University of Copenhagen, DK-2200, Copenhagen N, Denmark. ibenk@mfi.ku.dk

Pediatric Diabetes
|August 13, 2009
PubMed

Insights

Childhood low adiponectin predicts adolescent insulin insensitivity, especially in overweight children. High leptin indicated current insulin insensitivity but not future risk.

Area of Science:

  • Pediatric endocrinology
  • Metabolic health research
  • Diabetes risk assessment

Background:

  • Metabolic and inflammation biomarkers may indicate increased diabetes risk in children.
  • Childhood metabolic markers are crucial for predicting long-term health outcomes.

Purpose of the Study:

  • To investigate plasma adiponectin, leptin, IL-8, and hepatocyte growth factor (HGF) in children.
  • To determine their independent associations with insulin insensitivity, both cross-sectionally and prospectively over 6 years.

Main Methods:

  • Utilized data from the European Youth Heart Studies I and II (Danish children aged 8-10 and 14-16).
  • Employed cross-sectional and prospective linear regressions analyzing plasma biomarkers and insulin insensitivity (HOMA Z-scores).
  • Adjusted for multiple covariates including BMI, physical activity, and sexual maturity.

Main Results:

  • Lower baseline adiponectin was linked to insulin insensitivity 6 years later, particularly in overweight children.
  • Higher baseline leptin correlated with concurrent insulin insensitivity in younger children but not prospectively.
  • No significant associations were found for IL-8 or HGF.

Conclusions:

  • Childhood hypo-adiponectinaemia is directly associated with adolescent insulin insensitivity, with a stronger effect in overweight youth.
  • Hyper-leptinaemia in childhood is linked to current insulin insensitivity but does not predict future risk.
  • These findings highlight adiponectin as a key predictor of future metabolic dysfunction in children.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...